Comparative Evaluation of the Treatment Efficacy and Safety of TNFα and IL12/23 Inhibitors in Children With Psoriasis

Nikolay N. Murashkin; Eduard T. Ambarchian

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

User

eng | рус

Pediatric pharmacology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Murashkin N.N., Ambarchian E.T. Comparative Evaluation of the Treatment Efficacy and Safety of TNFα and IL12/23 Inhibitors in Children With Psoriasis. Pediatric pharmacology. 2018;15(6):455-463. (In Russ.) https://doi.org/10.15690/pf.v15i6.1983

Views PDF (Rus): 553

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Editor-in-Chief

Leyla S. Namazova-Baranova

Popular articles

* not an advertisement

Indexing Databases

* not an advertisement

Article Tools

Abstract

Print this article

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Nikolay N. Murashkin
National Medical Research Center for Children’s Health; Sechenov First Moscow State Medical University (Sechenov University); Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation
Russian Federation

Мурашкин Николай Николаевич, доктор медицинских наук, заведующий отделением дерматологии с группой лазерной хирургии

профессор кафедры дерматовенерологии и косметологии

профессор кафедры педиатрии и детской ревматологии

Адрес: 119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (499) 134-08-89

Eduard T. Ambarchian
National Medical Research Center for Children’s Health
Russian Federation

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

For citations:

Cookies policy